sham_vs_HIBD — integMET

Profile details

Identifier: MTBLS4933_0001_00000001
Linked study: MTBLS4933 — Sodium Butyrate mediates Histone Crotonylation and Alleviated Neonatal Rats Hypoxic-Ischemic Brain Injury Through Gut-Brain Axis (targeted SCFA brain metabolomics)
Comparison: sham vs HIBD
Group A: Control group with no hypoxic-ischemic brain damage or sodium butyrate treatment.. Provides a reference point for evaluating the effects of hypoxic-ischemic brain damage and sodium butyrate treatment.
Group B: Group with hypoxic-ischemic brain damage without sodium butyrate treatment.. Essential for understanding the baseline impact of hypoxic-ischemic brain damage.
Total features tested: 7
Significant features: 4
p-value threshold: 0.05
Ratio threshold (upper): 1.5
Ratio threshold (lower): 1/1.5
Date created: 2025-09-26 00:00:00

Metabolite ID (InChI Key)	Name	Direction	Ratio	p-value
KQNPFQTWMSNSAP-UHFFFAOYSA-N	2-METHYL-PROPIONIC ACID	down	1e-06	1.19e-08
FERIUCNNQQJTOY-UHFFFAOYSA-N	butyric acid	up	32.49	7.27e-09
GWYFCOCPABKNJV-UHFFFAOYSA-N	isovalerianic acid	down	0.3038	1.82e-07
XBDQKXXYIPTUBI-UHFFFAOYSA-N	PROPANOIC ACID	down	0.5526	7.68e-06